Quantinuum's (QNT) "Buy" Rating Reiterated at Rosenblatt Securities

Key Points

• Rosenblatt Securities reaffirmed its “Buy” rating on Quantinuum and set a $155 price target, implying 160.5% upside from the $59.50 share price. Analysts overall rate the stock “Moderate Buy,” with a consensus target of $98.42.
• Quantinuum shares were down 9.9% after the company reported a quarterly loss of $0.28 per share, missing the $0.26 consensus estimate, while revenue totaled $8 million.
• Insiders purchased 411,032 shares worth approximately $24.7 million over the past 90 days, including significant purchases by director Hal Barron and insider Kevin Scott Dehoff.

Quantinuum (NASDAQ:QNT - Get Free Report)'s stock had its "buy" rating reissued by equities researchers at Rosenblatt Securities in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $155.00 price target on the stock. Rosenblatt Securities' price target would indicate a potential upside of 160.50% from the stock's current price.

Other equities analysts also recently issued research reports about the company. TD Cowen began coverage on Quantinuum in a report on Monday, June 29th. They issued a "buy" rating on the stock. Cantor Fitzgerald reiterated an "overweight" rating and issued a $90.00 target price on shares of Quantinuum in a research note on Wednesday, August 12th. Morgan Stanley assumed coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued an "equal weight" rating and a $78.00 target price for the company. Mizuho started coverage on shares of Quantinuum in a research note on Monday, June 29th. They set an "outperform" rating and a $90.00 price target on the stock. Finally, Craig Hallum started coverage on shares of Quantinuum in a research note on Monday, June 29th. They issued a "buy" rating and a $100.00 price objective for the company. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $98.42.

Quantinuum Trading Down 9.9%

Shares of NASDAQ QNT opened at $59.50 on Wednesday. Quantinuum has a one year low of $47.06 and a one year high of $86.79. The company has a 50-day moving average price of $63.44.

Quantinuum (NASDAQ:QNT - Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.02). The firm had revenue of $8.00 million during the quarter. On average, equities research analysts anticipate that Quantinuum will post -1.64 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Kevin Scott Dehoff acquired 15,000 shares of Quantinuum stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $60.00 per share, for a total transaction of $900,000.00. Following the completion of the purchase, the insider owned 126,460 shares of the company's stock, valued at $7,587,600. This represents a 13.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Hal Barron acquired 250,000 shares of the firm's stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average cost of $60.00 per share, with a total value of $15,000,000.00. Following the completion of the acquisition, the director owned 255,833 shares in the company, valued at $15,349,980. This trade represents a 4,285.96% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders have purchased 411,032 shares of company stock valued at $24,661,920.

Institutional Investors Weigh In On Quantinuum

An institutional investor recently bought a new position in Quantinuum stock. Lisanti Capital Growth LLC acquired a new position in Quantinuum Inc. (NASDAQ:QNT - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 5,005 shares of the company's stock, valued at approximately $409,000.

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source